Opendata, web and dolomites

ABLE SIGNED

Home use, affordable and lightweight exoskeleton for people with lower-limb paralysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ABLE project word cloud

Explore the words cloud of the ABLE project. It provides you a very rough idea of what is the project "ABLE" about.

validate    people    independence    trl    extends    timeframe    self    limb    company    movement    everybody    off    professional    walk    restore    team    disruptive    patented    medical    awarded    first    palliating    algorithms    confidence    egrave    move    lower    de    health    allowed    eit    accelerator    sensor    acceleration    cnica    healthcare    mobility    exoskeleton    trained    flexes    robotic    walking    electric    exoskeletons    movements    supervision    expensive    sedentary    detects    commercialize    fit    mimicking    inertial    lightweight    caixaimpulse    model    18    business    centers    polit    massmedic    upc    boston    innovative    establishing    successful    caused    rehabilitation    leg    richi    intuitive    plan    lifestyle    again    assist    newly    home    boosting    found    restores    natural    intention    world    medtech    150    vision    actuator    injury    hospitals    paralysis    cimit    programs    heavy    possibility    affordable    independently    launch    helps    foundation    start    stakeholders    spin    human    universitat    motion    market    readiness    usa    had    ups    patient    device    trl9    won    catalunya   

Project "ABLE" data sheet

The following table provides information about the project.

Coordinator
ABLE HUMAN MOTION S.L. 

Organization address
address: SANT EUDALD 57 1 1
city: Barcelona
postcode: 8023
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.ablehumanmotion.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ABLE HUMAN MOTION S.L. ES (Barcelona) coordinator 50˙000.00

Map

 Project objective

People with lower-limb paralysis could walk again if they had a robotic exoskeleton to restore the leg movements affected by the injury. However, current devices are expensive (cost about 100 k€), heavy and require trained professional supervision. Therefore, they are only found in large hospitals and rehabilitation centers, and are out of the reach of the patient.

ABLE Human Motion is a medical device spin-off from Universitat Politècnica de Catalunya (UPC) that is developing and will commercialize robotic exoskeletons to enhance their mobility and independence. ABLE’s vision is to build a world where everybody has the possibility to move independently, with that aim we plan the launch of ABLE: the first home use, affordable and lightweight exoskeleton that restores the ability to walk of people with lower-limb paralysis in a natural and intuitive way. It is based on an electric actuator that flexes and extends the leg mimicking human natural movement, and an inertial sensor that together with dedicated algorithms detects the user’s intention to make the step forward. This patented and disruptive system to assist walking helps palliating health issues caused by sedentary lifestyle while boosting self-confidence and independence.

So far our newly established company has been awarded as an innovative technology to improve healthcare by CaixaImpulse and EIT Health. We have been selected among the 5 most promising medtech start-ups by MassMEDIC (Boston, USA). The team has also won the acceleration programs organized by Richi Foundation and CIMIT, the most successful health accelerator in the world. This has allowed us to validate the product-market fit with more than 150 stakeholders, establishing a viable business model and a go-to-market plan.

The project is currently at Technology Readiness Level (TRL) between 6 and 7, and should reach TRL9 within an 18-month timeframe.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABLE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABLE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

PICSOHF (2020)

PICSOHF, A minimally invasive cardiac intervention medical device to regenerate a damaged heart and extend the life of patients with Heart Failure

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More